
Sign up to save your podcasts
Or


Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
By The Motley Fool4.7
16041,604 ratings
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)

3,217 Listeners

1,482 Listeners

808 Listeners

944 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,715 Listeners

195 Listeners

833 Listeners

84 Listeners

584 Listeners

1,049 Listeners

56 Listeners